LIVE

CRVL

CorVel Corporation

CRVL

NASDAQ·Financial Services·Insurance - Brokers·Mkt cap $3.3B

$64.14

-0.54%

View full research view

Our plain-language verdict, the thesis, risk factors, and what is changing about the business.

View research view

52-Week Range

$44.83 - $103.06

P/E

31.44

Fwd P/E

Beta

0.98

Div Yield

0.00%

Avg Vol

222.8K

Shares Out

51.2M

Mkt Cap

$3.3B

Price action

Price chart

Down 36.4% over the trailing year

1W
1M
3M
6M
YTD
1Y
5Y
MAX

Total returns

Price performance

Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.

Why we rate it this way

The thesis at a glance

Bull and bear case · plain-English context across the five lenses we evaluate.

Bull Case

5 reasons

  • Proprietary AI and machine learning technology for claims automation and cost reduction
  • Integrated platform combining network solutions, patient management, and claims processing
  • Established relationships with major employers, insurers, and government agencies
  • Scale and operational efficiency in medical bill review and utilization management
  • Natural language processing capabilities for complex claims analysis

Bear Case

1 risk

  • Average volatility.

Growth

No forward estimates available

Rising healthcare costs driving demand for claims management and cost containment solutions

Value

Valuation data unavailable

Momentum

Strong

+18.4% over 3m

Quality

Stable

Excellent business quality

Dividend

None

No dividend

Earnings track record

Recent earnings results

AI-summarized recap of last quarter, plus the surprise on every print.

Next: Aug 4, 2026

Q2 26 RECAP

MAY 20, 2026

Earnings recap unavailable for this period.

EPS surprise · last 4Q

0 of 1 beats

Q2 26

Next: Aug 4, 2026

Revenue trend · last 8Q

+13%

+12%

+11%

+7%

+3%

Q4 24

Q1 24

Q2 24

Q3 24

Q4 25

Q1 25

Q2 25

Q3 25

$207.2M

$211.7M

$224.4M

$228.0M

$231.5M

$234.7M

$239.6M

$235.6M

Margins · last 8Q

Gross

23.3%

Operating

13.7%

Profit

10.3%

Wall Street consensus

Analyst coverage

Live ratings and price targets aggregated across covering analysts.

No analyst coverage on file for this stock yet.

vs Industry

How CRVL stacks vs Insurance - Brokers

Stock metrics vs industry averages. Green = better than industry.

Industry comparison data unavailable for this stock.